379 results
·
27ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT ARCHITECT AFP FOR THE ARCHITECT I2000SR ANALYZER
DIMENSION VISTA (R) AFP FLEX(R) REAGENT CARTRIDGE, MODEL K6454, DIMENSION VISTA (R) LOCI 5 CALIBRATOR, MODEL KC600
FDA 510(k)
FDA Class 2
·Immunology
EMAX 2 PLUS SYSTEM, MODEL EMAX 2 PLUS MOTOR, EMAX 2 CONSOLE>FIRMWARE UPGRADE, EMAX 2 FP FOOT PEDAL
FDA 510(k)
FDA Class 2
·Neurology
Cytomegalovirus (Cmv) Dna Quantitative Assay
FDA Pre-Market Approval
FDA Class 2
·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)
Cytomegalovirus (Cmv) Dna Quantitative Assay
FDA Pre-Market Approval
FDA Class 2
·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)
Cytomegalovirus (Cmv) Dna Quantitative Assay
FDA Pre-Market Approval
FDA Class 2
·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)
Cytomegalovirus (Cmv) Dna Quantitative Assay
FDA Pre-Market Approval
FDA Class 2
·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)
Cytomegalovirus (Cmv) Dna Quantitative Assay
FDA Pre-Market Approval
FDA Class 2
·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)
Cytomegalovirus (Cmv) Dna Quantitative Assay
FDA Pre-Market Approval
FDA Class 2
·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)
Cap, Cervical
FDA classification
FDA Class 2
·Cap, Cervical
Kit, Conception-Assist, Home Use
FDA classification
FDA Class 2
·Kit, Conception-Assist, Home Use
Cap, Device Disinfectant
FDA classification
FDA Class 2
·Cap, Device Disinfectant
Monitor, Airway Pressure (Includes Gauge And/Or Alarm)
FDA classification
FDA Class 2
·Monitor, Airway Pressure (Includes Gauge And/Or Alarm)
Valve, Non-Rebreathing
FDA classification
FDA Class 2
·Valve, Non-Rebreathing
Hemodialysis Catheter Luer End Cap
FDA classification
FDA Class 2
·Hemodialysis Catheter Luer End Cap
Procalcitonin Assay
FDA classification
FDA Class 2
·Procalcitonin Assay
In Situ Polymerizing Peripheral Nerve Cap
FDA classification
FDA Class 2
·In Situ Polymerizing Peripheral Nerve Cap
Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
FDA classification
FDA Class 2
·Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment
FDA classification
FDA Class 2
·Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment